In an experimental setup, HBO2 treatment has previously been demonstrated to downregulate IL-1β production, both in a model of zymosan-induced multi-organ failure [42], in a model of LPS-induced IL-1β production in human blood-derived monocyte-macrophages [50], and in a rat model of endocarditis [51]. Here, IL1B is linked to endocarditis.